Concurrent vaccination against equine influenza and equine herpesvirus – a practical approach
Open Access
- 2 July 2016
- journal article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 10 (5) , 433-437
Abstract
There is a lack of information concerning concurrent administration of vaccines against equine influenza virus (EIV) and equine herpesvirus 1 and 4 (EHV-1/4). The primary objective of this study was to determine the impact of the concurrent use of EIV and EHV-1/4 vaccines in Thoroughbred racehorses on their humoral immune response to EIV. This study was carried out on a population of 30 horses using an inactivated whole-virus EIV vaccine and an inactivated EHV-1/4 vaccine. Horses were randomly allocated to vaccination group A or B. Horses in group A were vaccinated against EIV and EHV-1/4 2 weeks apart. Horses in group B were vaccinated against EIV and EHV-1/4 on the same day. Whole-blood samples were collected on the day of vaccination and 2 weeks and 6 weeks post-vaccination. Antibody levels against EIV and EHV-1/4 were measured using the single radial haemolysis and serum neutralisation test, respectively. The pattern of EIV antibody response post-vaccination was similar for both groups. Highest EIV antibody levels were recorded 2 weeks post-vaccination, and a significant decrease in antibody level was observed 4 weeks later. Horses in group B demonstrated a significantly higher EIV antibody response post-vaccination. Overall, there was no significant difference in EHV-1/4 antibody response between the two groups post-vaccination. In this study, concurrent vaccination against EIV and EHV-1/4 increased the response to EIV and did not compromise the humoral immune response to EHV-1/4.Keywords
Funding Information
- Department of Agriculture, Food and the Marine
This publication has 15 references indexed in Scilit:
- Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010–2012)Influenza and Other Respiratory Viruses, 2013
- Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings—A blinded comparison of commercially available vaccinesVaccine, 2013
- Management and environmental factors involved in equine influenza outbreaks in Ireland 2007–2010Equine Veterinary Journal, 2011
- Control of EHV-1 viremia and nasal shedding by commercial vaccinesVaccine, 2010
- Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)Vaccine, 2006
- Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant maresVaccine, 2001
- Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997Veterinary Microbiology, 1999
- Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvantEpidemiology and Infection, 1994
- Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.1986
- IMMUNIZATION OF YOUNG HORSES AGAINST VIRAL RHINOPNEUMONITIS1963